GICRE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of General Insurance Corporation of India (GIC Re) approved an in-principle infusion of USD 49 million (approximately Rs 469 crore) into its Labuan, Malaysia branch. The purpose of this capital infusion is to restore solvency of the branch in line with the Insurance Capital Adequacy Framework set by the Labuan Financial Services Authority (LFSA). The approval is conditional, pending necessary regulatory clearances and formalities. The board meeting was held on 15th May 2026 from 5:15 PM to 6:17 PM IST and the disclosure was made under SEBI Regulation 30. GIC Re is a government-owned reinsurer listed on BSE (540755) and NSE (GICRE).
The capital infusion into the Labuan branch is a regulatory compliance measure and signals that the overseas operation needed solvency support. The amount (~$49 million / ~Rs 469 crore) is modest relative to GIC Re's overall scale, so the direct impact on the Indian listing is limited, though it confirms capital deployment into non-Indian operations.